ID   MT-W9/PL2
AC   CVCL_L172
SY   MTW9/PL2
DR   KCLB; 60003
DR   Wikidata; Q54906964
RX   PubMed=3338970;
RX   PubMed=11039493;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS:0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L171 ! MT-W9/PL
SX   Female
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
RX   PubMed=3338970; DOI=10.1007/BF02623814;
RA   Danielpour D., Riss T.L., Ogasawara M., Sirbasku D.A.;
RT   "Growth of MTW9/PL2 estrogen-responsive rat mammary tumor cells in
RT   hormonally defined serum-free media.";
RL   In Vitro Cell. Dev. Biol. 24:42-52(1988).
//
RX   PubMed=11039493; DOI=10.1290/1071-2690(2000)036<0410:EMAIDO>2.0.CO;2;
RA   Moreno-Cuevas J.E., Sirbasku D.A.;
RT   "Estrogen mitogenic action. I. Demonstration of estrogen-dependent
RT   MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in
RT   serum-supplemented culture and technical implications.";
RL   In Vitro Cell. Dev. Biol. Anim. 36:410-427(2000).
//